The current price of COYA is $2.99 — it has increased by 6.41% since the previous close. Data as of Nov 6, 2026.
COYA is down 17.86% over the past week, down 39.10% over the past month and down 48.09% over the past year. The price is below its 200-day moving average of $4.61.
Of the 7 analysts covering Coya Therapeutics, Inc., 7 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Coya Therapeutics, Inc. has a market capitalization of $70.14M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Coya Therapeutics, Inc. posted a loss of $0.28 per share against an estimate of -$0.3457, beating expectations by 19.01%. Upcoming reports are listed in the earnings calendar.
Coya Therapeutics, Inc. reported revenue of $221.87K in its most recent quarter, which has increased by 35.61% compared with the same quarter a year earlier. Analysts had expected $130K.
Coya Therapeutics, Inc. has not paid any dividends over the past year.
In the latest trading session COYA moved between $2.74 and $3.02, a range of 9.53% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Coya Therapeutics, Inc. shows a sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Coya Therapeutics, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks COYA has traded between $2.72 and $6.62. The current price is 54.83% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.